Critical Reviews In Therapeutic Drug Carrier Systems

Journal Title：Critical Reviews In Therapeutic Drug Carrier Systems

Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.

Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.

各种药物载体系统的治疗用途对许多慢性疾病的治疗和潜在治愈具有重大影响，包括癌症、糖尿病、牛皮癣、帕金森病、阿尔茨海默病、类风湿性关节炎、艾滋病毒感染、传染病、哮喘和药物成瘾。这些领域的科学努力涉及物理、生物、医学、制药、生物材料和工程等领域。

有关该领域的文章出现在各种各样的期刊上。随着文章数量的大幅增加和科学的碎片化趋势，跟上文献的步伐并整理和评估数据的重要性和可靠性变得越来越困难，尤其是在涉及专有考虑的情况下。如果不额外阅读原始文献，摘要和非批判性文章通常无法为正确评估特定领域提供足够可靠的基础。本期刊通过发表权威、客观、全面的多学科批判性评论论文来弥补这一差距，重点关注配方和给药系统。受邀文章和投稿文章均需经过同行评审。

Critical Reviews In Therapeutic Drug Carrier Systems创刊于1984年，由Begell House Inc.出版商出版，收稿方向涵盖药学 - 医学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 12周，或约稿 ，影响因子指数3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。